Sung-Wuk Kim
Gründer bei ImmunoMet Therapeutics, Inc.
Vermögen: 38 Mio $ am 30.04.2024
Profil
Sung-Wuk Kim is the founder of ImmunoMet Therapeutics, Inc. which was founded in 2015.
He currently holds the title of Chairman at ImmunoMet Therapeutics, Inc. Dr. Kim is also currently working as the Director at Korean Drug Research Association.
In the past, he held the position of President, Chief Executive Officer & Director at HANALL BIOPHARMA Co., Ltd.
from 2011 to 2014.
Dr. Kim also served as the Chief Executive Officer at Health Prime International LLC and as a Director at Bridge Biotherapeutics, Inc. Dr. Kim completed his undergraduate degree at Yonsei University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2023 | 1 469 702 ( 2,81% ) | 38 Mio $ | 30.04.2024 |
Aktive Positionen von Sung-Wuk Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| Korean Drug Research Association | Direktor/Vorstandsmitglied | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Gründer | 01.11.2017 |
Ehemalige bekannte Positionen von Sung-Wuk Kim
| Unternehmen | Position | Ende |
|---|---|---|
Health Prime International LLC
 Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Vorstandsvorsitzender | - |
| BRIDGE BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
| HANALL BIOPHARMA CO., LTD. | Vorstandsvorsitzender | - |
Ausbildung von Sung-Wuk Kim
| Yonsei University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HANALL BIOPHARMA CO., LTD. | Health Technology |
| BRIDGE BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Korean Drug Research Association | |
Health Prime International LLC
Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Commercial Services |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
